Xiangling Yang

3.6k citations
68 papers · 2.8k · h-index 30

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • RNA modifications and cancer
    • Circular RNAs in diseases
    • RNA Research and Splicing
    • Extracellular vesicles in disease
    • Cancer-related gene regulation

Papers in

    • RNA modifications and cancer 10
    • Circular RNAs in diseases 6
    • Wnt/β-catenin signaling in development and cancer 5
    • RNA Interference and Gene Delivery 4
    • MicroRNA in disease regulation 17
    • Cancer-related molecular mechanisms research 11

Xiangling Yang

67 papers receiving 2.8k citations

Peers

Xiangling Yang
Comparison fields: 5 of 107
  • Cancer Research 1.3k
  • Molecular Biology 1.8k
  • Oncology 346
  • Toxicology 32
  • Pharmacology 150
Replace Ku‐Chung Chen with:
Ku‐Chung Chen Taiwan
David Llobet‐Navàs Spain
In‐Chul Park South Korea
HyeSook Youn South Korea
Kaladhar B. Reddy United States
Hongxia Zhu China
Gerta Hoxhaj United States
Ninel Azoitei Germany
Jin‐Kun Wen China
Joslyn K. Brunelle United States
Xiangling Yang relative to Ku‐Chung Chen Taiwan Ku‐Chung Chen's profile →
Citations per field
00.5×1.5×
Ku‐Chung Chen · 1×
Citations per year

Countries citing papers authored by Xiangling Yang

Since Specialization
Citations

This map shows the geographic impact of Xiangling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangling Yang more than expected).

Fields of papers citing papers by Xiangling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangling Yang. The network helps show where Xiangling Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiangling Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiangling Yang Line = papers co-authored together Xiangling Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019312
2 2013158
3 2013146
4 2013124
5 2012114
6 2012113
7 2021102
8 201998
9 201992
10 201488
11 201986
12 201482
13 201578
14 201767
15 201166
16 201262
17 201662
18 201462
19 201555
20 201553

About Xiangling Yang

Xiangling Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pathology and Forensic Medicine, having authored 68 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers), Circular RNAs in diseases (6 papers), Wnt/β-catenin signaling in development and cancer (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer Cells and Metastasis (4 papers) and Nuclear Receptors and Signaling (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.8k citations), Oncology (346 citations), Toxicology (32 citations) and Pharmacology (150 citations). Xiangling Yang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Huanliang Liu, Burton B. Yang, Zina Jeyapalan Rutnam, William W. Du, Junxiong Chen, Jun Du, Hongsheng Wang, Lan Huang, Chuangyu Wen and Ling Fang. Their work appears in journals such as Oncotarget, PLoS ONE, Technology in Cancer Research & Treatment, Cell Death and Disease and Marine Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact